-
3
-
-
0242490778
-
Levetiracetam: treatment in epilepsy
-
Ben-Menachem E. Levetiracetam: treatment in epilepsy. Expert Opin Pharmacother 2003;4:2079-88.
-
(2003)
Expert Opin Pharmacother
, vol.4
, pp. 2079-2088
-
-
Ben-Menachem, E.1
-
4
-
-
44749083568
-
Thrombocytopenia during levetiracetam therapy
-
Meschede A, Runge U, Sabolek M. Thrombocytopenia during levetiracetam therapy. Epilepsy Res 2008;80:91-2.
-
(2008)
Epilepsy Res
, vol.80
, pp. 91-92
-
-
Meschede, A.1
Runge, U.2
Sabolek, M.3
-
5
-
-
0036856596
-
Verschlechterung einer Immunthrombopenie unter Monotherapie mit Levetiracetam
-
Hartmann H, Schumacher U, Seeck M. Verschlechterung einer Immunthrombopenie unter Monotherapie mit Levetiracetam. Akt Neurol 2002;29:467-8.
-
(2002)
Akt Neurol
, vol.29
, pp. 467-468
-
-
Hartmann, H.1
Schumacher, U.2
Seeck, M.3
-
6
-
-
79960049525
-
-
Levetiracetam-induced thrombocytopathia. American Epilepsy Society Meeting, San Diego
-
Herrman H, Taubøll E, Gjerstad L Levetiracetam-induced thrombocytopathia. American Epilepsy Society Meeting, San Diego, 2006.
-
(2006)
-
-
Herrman, H.1
Taubøll, E.2
Gjerstad, L.3
-
7
-
-
78650017520
-
Levetiracetam-induced thrombocytopenia among inpatients: a retrospective study
-
Sahaya K, Goyal MK, Sarwal A, Singh NN. Levetiracetam-induced thrombocytopenia among inpatients: a retrospective study. Epilepsia 2010;51:2492-5.
-
(2010)
Epilepsia
, vol.51
, pp. 2492-2495
-
-
Sahaya, K.1
Goyal, M.K.2
Sarwal, A.3
Singh, N.N.4
-
8
-
-
14844299427
-
Leucopenia and thrombocytopenia possible associated with lamotrigine use in a patient
-
Ural AU, Avcu F, Gökcil Z, Nevruz O, Cetin T. Leucopenia and thrombocytopenia possible associated with lamotrigine use in a patient. Epileptic Disord 2005;7:33-5.
-
(2005)
Epileptic Disord
, vol.7
, pp. 33-35
-
-
Ural, A.U.1
Avcu, F.2
Gökcil, Z.3
Nevruz, O.4
Cetin, T.5
-
9
-
-
35748954046
-
Myelodysplastic syndrome associated with chronic valproic acid therapy: a case report and review of the literature
-
Allan RW. Myelodysplastic syndrome associated with chronic valproic acid therapy: a case report and review of the literature. Hematology 2007;12:493-6.
-
(2007)
Hematology
, vol.12
, pp. 493-496
-
-
Allan, R.W.1
-
11
-
-
33746158512
-
Risk of aplastic anemia in patients using antiepileptic drugs
-
Handoko KB, Souverein PC, Van Staa TP et al. Risk of aplastic anemia in patients using antiepileptic drugs. Epilepsia 2006;47:1232-6.
-
(2006)
Epilepsia
, vol.47
, pp. 1232-1236
-
-
Handoko, K.B.1
Souverein, P.C.2
Van Staa, T.P.3
-
12
-
-
0033759937
-
Therapeutic safety monitoring-what to look for and when to look for it
-
Harden CL. Therapeutic safety monitoring-what to look for and when to look for it. Epilepsia 2000;41:37-44.
-
(2000)
Epilepsia
, vol.41
, pp. 37-44
-
-
Harden, C.L.1
-
13
-
-
0020061626
-
Carbamazepine and hematological monitoring
-
Hart RG, Easton JD. Carbamazepine and hematological monitoring. Ann Neurol 1982;11:309-12.
-
(1982)
Ann Neurol
, vol.11
, pp. 309-312
-
-
Hart, R.G.1
Easton, J.D.2
-
14
-
-
0025651807
-
A review of Carbamazepine's hematologic reactions and monitoring recommendations
-
Sobotka JL, Alexander B, Cook BL. A review of Carbamazepine's hematologic reactions and monitoring recommendations. DICP 1990;24:1214-9.
-
(1990)
DICP
, vol.24
, pp. 1214-1219
-
-
Sobotka, J.L.1
Alexander, B.2
Cook, B.L.3
-
16
-
-
39749201007
-
Valproate-induced thrombocytopenia: a prospective monotherapy study
-
Nasreddine W, Beydoun A. Valproate-induced thrombocytopenia: a prospective monotherapy study. Epilepsia 2008;49:438-45.
-
(2008)
Epilepsia
, vol.49
, pp. 438-445
-
-
Nasreddine, W.1
Beydoun, A.2
-
17
-
-
0026328079
-
Thrombocytopenia associated with carbamazepine: a case series
-
Tohen M, Castillo J, Cole JO, Miller MG, De Los HEROS R, Farrer RJ. Thrombocytopenia associated with carbamazepine: a case series. J Clin Psychiatry 1991;52:496-8.
-
(1991)
J Clin Psychiatry
, vol.52
, pp. 496-498
-
-
Tohen, M.1
Castillo, J.2
Cole, J.O.3
Miller, M.G.4
De Los Heros, R.5
Farrer, R.J.6
-
18
-
-
33746872168
-
Levetiracetam: a long-term follow-up study of efficacy and safety
-
Bauer J, Ben-Menachem E, Krämer G, Fryze W, Da Silva S, Kasteleijn-Nolst Trenité DG. Levetiracetam: a long-term follow-up study of efficacy and safety. Acta Neurol Scand 2006;114:169-76.
-
(2006)
Acta Neurol Scand
, vol.114
, pp. 169-176
-
-
Bauer, J.1
Ben-Menachem, E.2
Krämer, G.3
Fryze, W.4
Da Silva, S.5
Kasteleijn-Nolst Trenité, D.G.6
-
19
-
-
3042748137
-
The synaptic vesicle protein SV2A is the binding site for the antiepileptic drug levetiracetam
-
Lynch BA, Lambeng N, Nocka K et al. The synaptic vesicle protein SV2A is the binding site for the antiepileptic drug levetiracetam. Proc Natl Acad Sci 2004;101:9861-6.
-
(2004)
Proc Natl Acad Sci
, vol.101
, pp. 9861-9866
-
-
Lynch, B.A.1
Lambeng, N.2
Nocka, K.3
|